Aquablation Procedure Safe for BPH, With Durable Efficacy
Significant improvement seen in patient symptoms at 5 years; improvement also seen in mean maximum urinary flow rate
Diagnosis & Disease Information
5-ARIs May Protect Against Bladder Cancer Progression
5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
TURP Still Most Common BPH Procedure Despite Growing Use of Other Therapies
Some studies show that use of transurethral resection of the prostate, long the gold standard for managing enlarged prostates, is in decline, but it still remains the most popular choice among surgeons amid a wide range of options.
Prostate Artery Embolization Effective Long Term for Prostate-Related Urinary Symptoms
In less than 3 months after procedure, only mild urinary symptoms reported; benefits persisted through 6 years
High-Quality Surgical Videos Lacking for Vaporization of Prostate
Average video score was 6.65; only 24.3% of videos emphasized critical steps of surgery
5-ARIs Linked With Depression, But Not Suicide Risk
This Swedish population-based study has the largest sample size to date exploring these associations.
Poor Sleep Tied to Urinary, Prostate Symptoms
Association especially strong among the elderly male population
Lipid Ratios Linked to Benign Prostatic Hyperplasia Risk
TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C
Drug Repurposing Study Shows PDE5 Inhibitors Do Not Reduce Dementia Risk
By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.
Erectile Function Mostly Not Impacted by Surgery for BPH
But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia
- Loading...
Loading...
Next post in Benign Prostatic Hyperplasia (BPH)
Loading... 
Loading...